Replies to post #47644 on Biotech Values

[drbio45]

You asked for one such drug in a non-life threatening disease in the last 3 years. Those two limitations (non-life threatening and in the last 3 years) severely limit the size of the database. Almost certainly less than 10. So the chance that one of those, say, 8, would have threaded the needle is small. Not sure what more I can say that might make it clearer why your question as stated is unrealistic.

the fact that drugs aren't approved on that basis doesn't make the question unrealistic, it makes Forest's and Cypb's statements that the drug might be approved with a failed phase 3 unrealistic.

they will need the third phase 3 data, which is still enrolling, to to be positive for the drug to be approved